These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2546391)

  • 1. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat.
    Dray F; Gerozissis K; Fafeur V; Wisner A; Bommelaer-Bayet MC; Saadi M; Rougeot C; Tiberghien C; Junier MP
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():383-6. PubMed ID: 2546391
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies.
    Dray F; Wisner A; Bommelaer-Bayet MC; Tiberghien C; Gerozissis K; Saadi M; Junier MP; Rougeot C
    Ann N Y Acad Sci; 1989; 559():100-11. PubMed ID: 2549827
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
    Bito H; Kudo Y; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development of platelet-activating factor antagonists.
    Shen TY; Hussaini I; Hwang SB; Chang MN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.
    Sánchez Crespo M; Fernández-Gallardo S
    J Lipid Mediat; 1991; 4(2):127-43. PubMed ID: 1659463
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
    Shebzukhov IuV; Mysiakin EB
    Vopr Med Khim; 1996; 42(4):278-83. PubMed ID: 9254510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
    Harper MJ; Kudolo GB; Alecozay AA; Jones MA
    Prog Clin Biol Res; 1989; 294():305-15. PubMed ID: 2542988
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
    Borman RA; Jewell R; Hillier K
    Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
    Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J
    J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet-activating factor (PAF) receptor-related pathophysiology].
    Ishii S; Shimizu T
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1068-74. PubMed ID: 10396985
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 15. Homologous desensitization of PAF receptors via a PGE2-dependent pathway on intestinal smooth muscle.
    Jeanneton O; Delvaux M; Botella A; Frexinos J; Bueno L
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):331-44. PubMed ID: 7812681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet activating factor].
    Deguchi K; Murashima S; Deguchi A
    Nihon Rinsho; 1987 May; 45(5):1115-26. PubMed ID: 3041069
    [No Abstract]   [Full Text] [Related]  

  • 17. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia.
    Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y
    Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor.
    Hagi A; Hayashi H; Kishi K; Wang L; Ebina Y
    J Med Invest; 2000 Feb; 47(1-2):19-28. PubMed ID: 10740976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.
    Svetlov S; Nigam S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):162-6. PubMed ID: 8380690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of platelet activating factor on blood platelets].
    Fu JM
    Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):40-4. PubMed ID: 2549618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.